PH16296A - Quinolinyl guanidines having antiinflammatory,analgesic or antipyretic activity - Google Patents

Quinolinyl guanidines having antiinflammatory,analgesic or antipyretic activity

Info

Publication number
PH16296A
PH16296A PH21790A PH21790A PH16296A PH 16296 A PH16296 A PH 16296A PH 21790 A PH21790 A PH 21790A PH 21790 A PH21790 A PH 21790A PH 16296 A PH16296 A PH 16296A
Authority
PH
Philippines
Prior art keywords
guanidines
antiinflammatory
quinolinyl
analgesic
antipyretic activity
Prior art date
Application number
PH21790A
Other languages
English (en)
Inventor
Rachlin Schneur
Edgardo Arrigonimartelli
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of PH16296A publication Critical patent/PH16296A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
PH21790A 1977-11-07 1978-11-02 Quinolinyl guanidines having antiinflammatory,analgesic or antipyretic activity PH16296A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4616677 1977-11-07

Publications (1)

Publication Number Publication Date
PH16296A true PH16296A (en) 1983-09-05

Family

ID=10440127

Family Applications (1)

Application Number Title Priority Date Filing Date
PH21790A PH16296A (en) 1977-11-07 1978-11-02 Quinolinyl guanidines having antiinflammatory,analgesic or antipyretic activity

Country Status (24)

Country Link
US (1) US4293549A (is")
JP (1) JPS5473784A (is")
AT (1) AT366368B (is")
AU (1) AU517670B2 (is")
BE (1) BE871807A (is")
CA (1) CA1120929A (is")
CH (1) CH645354A5 (is")
DE (1) DE2847792A1 (is")
DK (1) DK153950C (is")
ES (1) ES474900A1 (is")
FI (1) FI69463C (is")
FR (1) FR2407930A1 (is")
GR (1) GR65010B (is")
IE (1) IE47458B1 (is")
IT (1) IT1100075B (is")
LU (1) LU80476A1 (is")
NL (1) NL7811035A (is")
NZ (1) NZ188770A (is")
PH (1) PH16296A (is")
PT (1) PT68750A (is")
SE (1) SE446267B (is")
SU (1) SU828967A3 (is")
YU (1) YU41129B (is")
ZA (1) ZA786175B (is")

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306846B1 (en) * 1972-05-31 2001-10-23 John R. J. Sorenson Anti-inflammatory and anti-ulcer compounds and process
IT1205640B (it) * 1983-04-06 1989-03-23 Yason Srl Nuovi composti ad attivita' antiinfiammatoria,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US4563460A (en) * 1984-01-13 1986-01-07 William H. Rorer, Inc. Quinoline and quinazoline derivatives for treating gastrointestinal motility dysfunctions
HU195487B (en) * 1985-06-04 1988-05-30 Egyt Gyogyszervegyeszeti Gyar Process for producing quinoline derivatives
ES2031514T3 (es) * 1986-08-29 1992-12-16 Pfizer Inc. 2-guanidino-4-ariltiazoles para el tratamiento de ulceras pepticas.
US6100260A (en) * 1997-04-21 2000-08-08 Sumitomo Pharmaceutical Company, Limited Isoxazole derivatives
EP0928793B1 (en) * 1998-01-02 2002-05-15 F. Hoffmann-La Roche Ag Thiazole derivatives
RU2202344C2 (ru) 1998-03-26 2003-04-20 Джапан Тобакко Инк. Антагонисты ноцицептина, производные амида, аналгетик, способ инициирования антагонистического действия к ноцицептину, способ лечения боли, фармацевтические композиции
EP1237849A1 (en) * 1999-11-05 2002-09-11 University College London Activators of soluble guanylate cyclase
AU2003303678A1 (en) * 2003-01-03 2004-08-10 Genzyme Corporation Urea derivatives and their use as anti-inflammatory agents
ES2387909T3 (es) * 2003-01-14 2012-10-03 Cytokinetics, Inc. Compuestos, composiciones y procedimientos de tratamiento de la insuficiencia cardiaca
GB0404434D0 (en) 2004-02-27 2004-03-31 Novartis Ag Organic compounds
US9296697B2 (en) * 2005-08-24 2016-03-29 Abbott Laboratories Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-HT5-receptors
WO2023003497A1 (ru) * 2021-07-23 2023-01-26 Общество С Ограниченной Ответственностью "Валента-Интеллект" Соединения с лизосомотропной и противовирусной активностью

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB889282A (en) * 1957-05-07 1962-02-14 Air Reduction Preparation of hexafluorodiethyl ether and medicinal compositions containing it
GB889262A (en) * 1959-07-03 1962-02-14 Ciba Ltd Quinoline compounds
US3159676A (en) * 1962-02-07 1964-12-01 Smith Kline French Lab Naphthyl containing guanidines
US3852293A (en) 1972-06-21 1974-12-03 Uniroyal Inc 4-phenyl-2-(3-pyridyl)-thiazole carboxamides
US4000279A (en) * 1974-10-29 1976-12-28 Armour Pharmaceutical Company Pharmaceutical preparations containing 5'-(8'-hydroxyquinolyl)guanidine compounds and methods of using same

Also Published As

Publication number Publication date
JPS6348873B2 (is") 1988-09-30
ZA786175B (en) 1979-10-31
DK153950C (da) 1989-02-20
DK153950B (da) 1988-09-26
PT68750A (en) 1978-12-01
IE47458B1 (en) 1984-03-21
SE7811457L (sv) 1979-05-08
US4293549A (en) 1981-10-06
NZ188770A (en) 1984-07-31
DK493378A (da) 1979-05-08
GR65010B (en) 1980-06-12
ATA773278A (de) 1981-08-15
IT1100075B (it) 1985-09-28
FI69463C (fi) 1986-02-10
LU80476A1 (fr) 1979-06-15
ES474900A1 (es) 1980-04-16
DE2847792C2 (is") 1988-02-04
FR2407930A1 (fr) 1979-06-01
AT366368B (de) 1982-04-13
FI783327A7 (fi) 1979-05-08
IE782084L (en) 1979-05-07
DE2847792A1 (de) 1979-05-10
AU4137678A (en) 1979-05-17
SU828967A3 (ru) 1981-05-07
NL7811035A (nl) 1979-05-09
IT7829514A0 (it) 1978-11-07
FR2407930B1 (is") 1983-03-18
YU257578A (en) 1983-01-21
CA1120929A (en) 1982-03-30
YU41129B (en) 1986-12-31
JPS5473784A (en) 1979-06-13
CH645354A5 (de) 1984-09-28
BE871807A (fr) 1979-05-07
SE446267B (sv) 1986-08-25
FI69463B (fi) 1985-10-31
AU517670B2 (en) 1981-08-20

Similar Documents

Publication Publication Date Title
NL7706217A (nl) Uitwisselreactie.
JPS53118904A (en) Word converter
JPS531815A (en) Dccdc converter
JPS538724A (en) Dccdc converter
JPS5416389A (en) Catalyst
NL7714187A (nl) Tegenstroomkristallisator.
PH16296A (en) Quinolinyl guanidines having antiinflammatory,analgesic or antipyretic activity
AU510781B2 (en) Polygerization catalyst
PH14778A (en) 4d,5d-epoxy 17b-hydroxy-4,17-dimethyl-3-oxo-androstane-2d-carbonitrile
JPS52149316A (en) Dccdc converter
JPS5298456A (en) Analoggtoodigital converter
ZA785564B (en) Analgesic compounds
EG13533A (en) 1,2-benzisoxazoloxyacetic acid and related compounds
GB2010870B (en) Polymerisaton catalyst
NL7800537A (nl) Band.
NL7713929A (nl) Vignolewissel.
JPS5355947A (en) Analoggtoodigital converter
JPS5432633A (en) Antipyretic agent
GB1538874A (en) Catalytic crackers
IL55865A0 (en) 4-desacetoxy-4-oxovinblastine, 4-descetoxy-4-alpha-hydroxyvinblastine and related compounds
NL7806416A (nl) Omrichtschakeling.
JPS5349482A (en) Electricityytoosound converter
GB2009120B (en) Catalysis
IT7825377A0 (it) Polipeptide analgesico.
JPS53100185A (en) Catalyst and the manufacture